Cardiac cell therapy: overexpression of connexin43 in skeletal myoblasts and prevention of ventricular arrhythmias

Cell-based therapies have great potential for the treatment of cardiovascular diseases. Recently, using a transgenic mouse model Roell et al. reported that cardiac engraftment of connexin43 (Cx43)-overexpressing myoblasts in vivo prevents post-infarct arrhythmia, a common cause of death in patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernandes, Sarah, van Rijen, Harold VM, Forest, Virginie, Evain, Stéphane, Leblond, Anne-Laure, Mérot, Jean, Charpentier, Flavien, de Bakker, Jacques MT, Lemarchand, Patricia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2009
Materias:
Cell Therapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3189515/
https://www.ncbi.nlm.nih.gov/pubmed/19438811
http://dx.doi.org/10.1111/j.1582-4934.2009.00740.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3189515/
https://www.ncbi.nlm.nih.gov/pubmed/19438811
http://dx.doi.org/10.1111/j.1582-4934.2009.00740.x

Ejemplares similares